麻豆传媒

Members of a House committee sent FDA Commissioner Robert Califf, MD, a letter urging the agency to take a closer look at some pharma companies' "alarming practice" of . (BioSpace)

Regeneron announced that the FDA linvoseltamab for relapsed/refractory multiple myeloma at the current time because of manufacturing issues related to a third-party facility.

What can oncologists learn from a ? (Oncology News Central)

Galapagos NV announced FDA clearance to launch a phase I/II trial of its autologous CD19 CAR-T cell therapy product candidate GLPG5101 for non-Hodgkin lymphoma using their that aims to reduce CAR T-cell processing time to 7 days.

The U.S. Office of Research Integrity has accused a former cancer researcher at the University of Maryland, whose funded work included 19 NIH grants, of in more than a dozen published papers. (Retraction Watch)

Preliminary clinical results suggest the PARP inhibitor olaparib (Lynparza) can achieve responses in without the use of hormonal therapy. (Johns Hopkins, JAMA Oncology)

An artificial intelligence program showed potential to improve understanding of the risk of . (JACC: CardioOncology)

The American Cancer Society and Color Health announced the launch of a pilot program to distribute to people living in rural and other underserved areas.

A meditation technique called "mindful breathing" may help in patients with cancer. (U.S. News & World Report)

AIM ImmunoTech reported from a clinical trial evaluating the TLR-3 receptor agonist rintatolimod (Ampligen) in pancreatic cancer.

Do agricultural practices in Iowa contribute to the state's , which is second in the U.S.? (Des Moines Register)

Second-generation androgen-targeting drugs outperform chemotherapy for , but the results depend on the types of mutations that drive a specific patient's cancer. (Karolinska Institute, Nature Medicine)

Comment